UW–Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination — including a COVID-19 vaccine that has advanced to clinical trials.
Neuromodulation therapies can reduce epileptic seizures, soothe chronic pain and treat depression. Now, a significant advance could dramatically reduce their cost, increase their reliability and make them much less invasive.
Researchers at the University of Wisconsin–Madison have packed a gene-editing payload into a customizable, synthetic nanocapsule.
A team of biomedical engineers and clinician-scientists borrowed molecules from the immune system of the parasitic sea lamprey to deliver anti-cancer drugs directly to brain tumors.
Thanks, in part, to pigs at the Arlington Agricultural Research Station, scientists now are catching up on understanding the roots of calcific aortic valve disease.
The prospect of regenerating bone lost to cancer or trauma is a step closer to the clinic.